CytoDyn to Deliver Presentation at Biotech Showcas
Post# of 145456
![Avatar](/images/ProfileImages/167738657_59587_mando klein.jpg)
Download as PDFJanuary 09, 2020 1:22pm EST
VANCOUVER, Washington, Jan. 09, 2020 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company"
![](/images/icons/icon_wink.gif)
Nader Pourhassan, Ph.D., President and CEO of CytoDyn, will present an overview of the Company’s clinical programs and provide insights into his vision for CytoDyn in 2020, starting with its first BLA submission of leronlimab (PRO 140) and the future of leronlimab as a potential cancer therapy. Dr. Pourhassan’s presentation is Monday, January 13 at 10:30 a.m. PT and a live webcast and replay of the presentation will be available here and on the Investors section of the Company’s website, https://www.cytodyn.com/. This presentation will be followed by a breakout Q&A open to the conference participants. The webcast will be available approximately two hours after the webcast presentation ends and will be accessible for 90 days.
CONTACTS
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)